StonvexLoading…
StonvexStonvexStonvexCore line items from AMBP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.50B | $4.91B | $4.81B | $4.69B |
Operating Income | $244.00M | $202.00M | $76.00M | $176.00M |
Net Income | $11.00M | $-3.00M | $-50.00M | $237.00M |
EPS (Diluted) | $-0.02 | $-0.05 | $-0.12 | $0.38 |
Total Assets | $5.68B | $5.46B | $5.67B | $5.87B |
Total Liabilities | $6.35B | $5.60B | $5.56B | $5.41B |
Cash & Equivalents | $208.00M | $214.00M | $324.00M | $469.00M |
Free Cash Flow OCF − CapEx | $276.00M | $283.00M | $248.00M | $-380.00M |
Shares Outstanding | Not available | 597.70M | 597.60M | 597.00M |